Clinical Trial

Exploring the Utility of [18F]3F4AP for Demyelination Imaging

Name: Exploring the Utility of [18F]3F4AP for Demyelination Imaging — clinical trial record (NCT06999434)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The overall objective is to obtain an assessment of the pharmacokinetics of \[18F\]3F4AP in healthy volunteers and subjects with demyelinating diseases such as mild cognitive impairment (MCI), Alzheimer's Disease (AD), Multiple Sclerosis (MS), Spinal Cord Injury (SCI) and Spinal radiculopathy (SR).

Trial Details

NCT Number	NCT06999434
Lead Sponsor	Yale University Collaborators: National Institute for Biomedical Imaging and Bioengineering (NIBIB), National Institute on Aging (NIA)
Conditions	Demyelinating Disorders, MCI, Alzheimer's Disease (AD), MS (Multiple Sclerosis), SCI - Spinal Cord Injury, Spinal Radiculopathy
Enrollment	105 participants
Start Date	2025-05-05
Primary Completion	2030-05-05 (estimated)
Study Completion	2030-05-05 (estimated)
Updated on ClinicalTrials.gov	2025-05-31